Clinical Trials Browser

Breast Neoplasms

NCT02883062 2026-04-13

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Phase 2 Active not recruiting

67 enrolled 16 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02348684 2026-04-01

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

Completed

20 enrolled 5 charts

Breast

Breast Neoplasms

NCT04266249 2026-03-23

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Phase 2 Active not recruiting

2,175 enrolled

Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT03909282 2026-03-12

NORDIS

Phase NA Recruiting

50 enrolled

Breast

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast

NCT06704659 2026-03-09

RAY-no-BAN

Phase NA Recruiting

60 enrolled

Breast

Breast Neoplasms, Recurrence

NCT07053085 2026-02-27

A Study of Surgery and Radiotherapy in People With Breast Cancer

Phase 2 Recruiting

162 enrolled

Breast

Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

Phase 1/2 Not yet recruiting

84 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05527769 2026-02-13

DREAM-RMI

Completed

27 enrolled

Breast

Breast Cancer Female

NCT02624973 2026-02-12

PETREMAC

Phase 2 Active not recruiting

200 enrolled

Breast

Breast Neoplasms

NCT01796197 2026-02-05

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Phase 2 Completed

23 enrolled 10 charts

Breast

Breast Neoplasms

NCT06092892 2025-12-10

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Phase 2 Recruiting

45 enrolled

Breast

Breast Neoplasms, Lymphedema

NCT06888388 2025-12-08

NSM

Recruiting

4,700 enrolled

Hamartoma Syndrome, Multiple, Li-Fraumeni Syndrome

NCT00210236 2025-10-20

AXIL95

Phase 3 Terminated

625 enrolled 8 charts

Breast

Breast Neoplasms

NCT07187752 2025-09-23

Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes

Phase NA Not yet recruiting

1,039 enrolled

Breast

Breast Neoplasms

NCT01841749 2025-09-12

CINNAMOME

Completed

228 enrolled 4 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06839001 2025-06-26

CRYSTAL - SIX

Phase 3 Recruiting

750 enrolled

Breast

Breast Neoplasms

NCT04585074 2025-05-15

MARRES

Active not recruiting

2,000 enrolled

Breast

Breast Neoplasms, Cystic Fibrosis

Clinical Trials

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

NORDIS

RAY-no-BAN

A Study of Surgery and Radiotherapy in People With Breast Cancer

NoCUT-BC

DREAM-RMI

PETREMAC

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

NSM

AXIL95

Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes

CINNAMOME

CRYSTAL - SIX

MARRES